tiprankstipranks
Advertisement
Advertisement

BCYC Stock Latest News

Bicycle Therapeutics assumed with an Outperform at Oppenheimer
The FlyBicycle Therapeutics assumed with an Outperform at Oppenheimer
3d ago
BCYC
Bicycle Therapeutics reports Q2 EPS (72c), consensus (58c)
PremiumThe Fly
Bicycle Therapeutics reports Q2 EPS (72c), consensus (58c)
4d ago
BCYC
Bicycle Therapeutics sees cash runway into 2030
PremiumThe Fly
Bicycle Therapeutics sees cash runway into 2030
4d ago
BCYC
Bicycle Therapeutics Shareholders Approve Proposals at 2026 AGM
PremiumCompany Announcements
Bicycle Therapeutics Shareholders Approve Proposals at 2026 AGM
2M ago
8K
BCYC
Bicycle Therapeutics Reports Positive Duravelo-2 Phase 2 Data
PremiumCompany Announcements
Bicycle Therapeutics Reports Positive Duravelo-2 Phase 2 Data
2M ago
8K
BCYC
Bicycle Therapeutics price target lowered to $12 from $13 at Jefferies
PremiumThe FlyBicycle Therapeutics price target lowered to $12 from $13 at Jefferies
3M ago
BCYC
Analyst Initiates Buy Rating on Nuzetide Developer, Citing Differentiated Efficacy in Urothelial Cancer and Advancing Pancreatic Cancer Program
Premium
Ratings
Analyst Initiates Buy Rating on Nuzetide Developer, Citing Differentiated Efficacy in Urothelial Cancer and Advancing Pancreatic Cancer Program
3M ago
BCYC
Bicycle Therapeutics reports Q1 EPS (87c), consensus (65c)
Premium
The Fly
Bicycle Therapeutics reports Q1 EPS (87c), consensus (65c)
3M ago
BCYC
Bicycle Therapeutics: Early EphA2-Targeted Data and Multi-Tumor Expansion Potential Support Buy Rating and Upside to Valuation
PremiumRatings
Bicycle Therapeutics: Early EphA2-Targeted Data and Multi-Tumor Expansion Potential Support Buy Rating and Upside to Valuation
3M ago
BCYC
Bicycle Therapeutics announces updates from EphA2 pipeline at AACR meeting
PremiumThe Fly
Bicycle Therapeutics announces updates from EphA2 pipeline at AACR meeting
3M ago
BCYC
Bicycle Therapeutics Advances EphA2 Oncology Pipeline With New Data
PremiumCompany Announcements
Bicycle Therapeutics Advances EphA2 Oncology Pipeline With New Data
3M ago
8K
BCYC
Bicycle Therapeutics price target lowered to $12 from $13 at Morgan Stanley
PremiumThe Fly
Bicycle Therapeutics price target lowered to $12 from $13 at Morgan Stanley
4M ago
BCYC
Bicycle Therapeutics: Portfolio Refocus and Cost Cuts Extend Cash Runway, Strengthening Risk‑Reward and Supporting Buy Rating
PremiumRatingsBicycle Therapeutics: Portfolio Refocus and Cost Cuts Extend Cash Runway, Strengthening Risk‑Reward and Supporting Buy Rating
4M ago
BCYC
Bicycle Therapeutics price target lowered to $7 from $11 at RBC Capital
Premium
The Fly
Bicycle Therapeutics price target lowered to $7 from $11 at RBC Capital
5M ago
BCYC
Bicycle Therapeutics price target lowered to $36 from $44 at Oppenheimer
Premium
The Fly
Bicycle Therapeutics price target lowered to $36 from $44 at Oppenheimer
5M ago
BCYC
Bicycle Therapeutics price target lowered to $8 from $12 at Citizens
PremiumThe Fly
Bicycle Therapeutics price target lowered to $8 from $12 at Citizens
5M ago
BCYC
Bicycle Therapeutics price target lowered to $8 from $10 at Truist
PremiumThe Fly
Bicycle Therapeutics price target lowered to $8 from $10 at Truist
5M ago
BCYC
Bicycle Therapeutics reports Q4 EPS (29c), consensus (95c)
PremiumThe Fly
Bicycle Therapeutics reports Q4 EPS (29c), consensus (95c)
5M ago
BCYC
BCYC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
BCYC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
BCYC
Bicycle Therapeutics CFO Alethia Young steps down, Travis Thompson succeeds
PremiumThe FlyBicycle Therapeutics CFO Alethia Young steps down, Travis Thompson succeeds
6M ago
BCYC
Bicycle Therapeutics CMO Eric Westin retires, Michael Method succeeds
Premium
The Fly
Bicycle Therapeutics CMO Eric Westin retires, Michael Method succeeds
6M ago
BCYC
Bicycle Therapeutics names Michael Skynner chief scientific officer
Premium
The Fly
Bicycle Therapeutics names Michael Skynner chief scientific officer
6M ago
BCYC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >